Michael Raab - Sep 11, 2024 Form 4 Insider Report for ARDELYX, INC. (ARDX)

Role
President & CEO, Director
Signature
/s/ Elizabeth Grammer, Attorney-in-Fact for Michael Raab
Stock symbol
ARDX
Transactions as of
Sep 11, 2024
Transactions value $
-$161,749
Form type
4
Date filed
9/13/2024, 04:35 PM
Previous filing
Aug 28, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ARDX Common Stock Options Exercise $34.7K +35K +2.87% $0.99 1.26M Sep 11, 2024 Direct F1, F2
transaction ARDX Common Stock Sale -$196K -35K -2.79% $5.61 1.22M Sep 11, 2024 Direct F1, F2, F3
holding ARDX Common Stock 24.4K Sep 11, 2024 Family Trust F4
holding ARDX Common Stock 1K Sep 11, 2024 Family Trust F5

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ARDX Stock Option (Right to Buy) Options Exercise $0 -35K -5.79% $0.00 570K Sep 11, 2024 Common Stock 35K $0.99 Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Transaction was made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 13, 2023.
F2 Reflects the adjusted total which includes the purchase of 1,099 shares under the Ardelyx Employee Stock Purchase Plan in August 2024.
F3 Transaction was executed in multiple trades in prices ranging from $5.551 to $5.651, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F4 The shares are directly held by Michael G. Raab, Trustee of the Michael G. Raab Living Trust dated July 25, 2012.
F5 The shares are owned directly by trusts for the benefit of the Reporting Person's children.
F6 The option becomes exercisable as it vests and the shares subject to the option vest in 48 successive, equal monthly installments on each monthly anniversary of January 6, 2022, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.